ArticleArchives of pharmacal research2025

Histone demethylase KDM4C confers temozolomide resistance to glioblastoma cells by epigenetically regulating E2F6.

Go Woon Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.